Laurion Capital Management’s Novavax NVAX Stock Holding History

Laurion Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-110,822	Closed	-$8.16M	–	640
2022 Q1	$8.16M	Buy	+110,822	New	+$9.88M	0.1%	129
2021 Q3	–	Sell	-2,271	Closed	-$482K	–	817
2021 Q2	$482K	Buy	+2,271	New	+$416K	﹤0.01%	520
2020 Q4	–	Sell	-9,800	Closed	-$1.06M	–	878
2020 Q3	$1.06M	Buy	+9,800	New	+$1.19M	0.01%	411
2015 Q2	–	Sell	-17,686	Closed	-$2.92M	–	670
2015 Q1	$2.92M	Buy	+17,686	New	+$2.87M	0.06%	196
2014 Q3	–	Sell	-17,895	Closed	-$1.65M	–	367
2014 Q2	$1.65M	Buy	+17,895	New	+$1.57M	0.03%	201

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Laurion Capital Management's NVAX Position: Q2 2022 in Review

Laurion Capital Management sold out of Novavax (NVAX) in Q2 2022, closing a stake of 110,822 shares — an estimated $8.16M sold.

Laurion Capital Management first reported a position in NVAX in Q2 2014 and held it in 5 quarters. The position peaked at $8.16M in Q1 2022. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

Laurion Capital Management reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
Laurion Capital Management sold 110,822 Novavax shares in Q2 2022, an estimated $8.16M.
Laurion Capital Management first reported a position in Novavax in Q2 2014 and held it in 5 quarters.
Laurion Capital Management's Novavax position peaked at $8.16M in Q1 2022.
325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on Laurion Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.